Article
Pancreatic function and extended mutation analysis in DeltaF508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levels.
The Journal of pediatrics - 1 Aug 2000
Massie R J, Wilcken B, Van Asperen P, Dorney S, Gruca M, Wiley V, Gaskin K
Abstract excerpt
BACKGROUND: Newborn screening for cystic fibrosis (CF) with immunoreactive trypsinogen (IRT) and DeltaF508 analysis followed by sweat testing misses some infants with CF and detects more DeltaF508 carriers than expected. Some of the apparent DeltaF508 carriers may be DeltaF508 compound heterozygotes with normal sweat electrolyte levels. METHODS: Infants identified by newborn screening with an elevated IRT level,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
